This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sangamo BioSciences' CEO Presents At The 2012 Wedbush PacGrow Lifesciences Management Access Conference (Transcript)

Sangamo BioSciences, Inc. (SGMO)

2012 Wedbush PacGrow Lifesciences Management Access Conference

August 14, 2012 9:10 AM ET

Executives

Edward Lanphier – CEO

Geoff Nichol – EVP, Research and Development

Analysts

Liana Moussatos – Wedbush Securities

Presentation

Liana Moussatos

Okay. We’ll get started. I’m Liana Moussatos from Wedbush, and today we have the CEO of Sangamo, Edward Lanphier, who will give us a corporate presentation followed by Q&A. Edward?

Edward Lanphier

Good morning. I don’t know why it is that West Coast companies draw the short straw and get the early morning talks, but I’m fully caffeinated and ready to go. Good morning, Liana. Thanks so much for including us in this year’s conference. In addition to myself, I’m joined here upfront by my colleague, Geoff Nichol, who is our EVP of Research and Development, and also in the audience, my colleague, Dr. Elizabeth Wolffe, Head of Corporate Communications.

My presentation today will contain forward-looking statements. I refer you to our Forms 10-K and 10-Q filed with the SEC for additional information. Before diving in to the presentation, Liana has asked that maybe I go through this relatively quickly. I won’t try and speak coherently in the morning here, but leaving time for questions and happy to do so.

So as we dive in, just to remind you, Sangamo is unique, unique in a very specific way, and that is our core technology provides an opportunity to engineer a naturally occurring class of DNA-binding proteins, the most common, the most abundant class or type of DNA-binding protein found on our planet, from humans all the way down to worms and flies and so on. These are called zinc finger DNA-binding proteins, and these are small, about 30 amino acids. They’re modular proteins that nature was able to use or engineer to bind to unique sequences of DNA as genomes became larger and larger.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs